Xiao Dong | Cancer | Innovative Research Award

Published on by Medical Lab Scientist

Innovative Research Award

Xiao Dong
Affiliation Shanghai University
Country China
Scopus ID 56457039700
Documents 30
Citations 1,898
h-index 17
Subject Area Cancer
Event Medical Lab Scientist Awards
ORCID 0000-0001-6897-6999

Xiao Dong is a researcher associated with Shanghai University whose academic work includes cancer-related biomaterials, nanomedicine, tumor-responsive therapeutic systems, and cancer immunotherapy. His scholarly profile identifies research activity at the interface of biomedical materials, drug-delivery technology, tumor biology, and therapeutic innovation.[1]

Abstract

This academic recognition profile summarizes the research record of Xiao Dong in the broad subject area of cancer, with particular emphasis on biomedical materials, nanomedicine, tumor-responsive therapeutic platforms, and cancer immunotherapy. Recent published research associated with Dong includes the development of a hypochlorous acid-responsive prodrug nanoplatform designed to integrate tumor-responsive drug activation with immunotherapeutic mechanisms[1]

Keywords

Cancer, cancer immunotherapy, nanomedicine, biomaterials, tumor microenvironment, drug delivery, prodrug nanoplatform, tumor-responsive therapy, STING agonist, biomedical engineering, anticancer therapeutics, immune response, translational research, Shanghai University, medical research, therapeutic innovation.[2]

Introduction

Cancer research increasingly integrates molecular biology, immunology, materials science, pharmacology, and bioengineering to address challenges associated with treatment resistance, tumor heterogeneity, systemic toxicity, and the immunosuppressive tumor microenvironment. Nanomedicine represents one interdisciplinary approach in which engineered materials are investigated as carriers or responsive platforms for delivering therapeutic agents to tumors.[2]

Research Profile

Xiao Dong is associated with Shanghai University in China. Published work identifies affiliations that include Shanghai 411 Hospital/Shanghai University and the Institute of Artificial Intelligence and Biomanufacturing within the School of Medicine at Shanghai University. His ORCID identifier is 0000-0001-6897-6999, providing a persistent identifier for attribution and discovery of scholarly activity. [3]

Research Contributions

A notable component of Xiao Dong’s research concerns the application of engineered nanomedicine systems to cancer therapy. In a 2026 study published in Biomaterials Research, Dong and collaborators reported a hypochlorous acid-responsive prodrug nanoplatform for synergistic cancer immunotherapy. The experimental system combined a stimulus-responsive methylene blue–doxorubicin dimer prodrug with a stimulator of interferon genes agonist, with the objective of coordinating tumor-responsive therapeutic activity and antitumor immune stimulation. [3]

Publications

Hypochlorous Acid-Responsive Prodrug Nanoplatform for Synergistic Cancer Immunotherapy. Published in Biomaterials Research in 2026, this investigated a responsive prodrug nanoplatform combining chemotherapy-related mechanisms with immune activation for experimental cancer treatment.Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy. [4]

Research Impact

The supplied Scopus indicators report 30 indexed documents, 1,898 citations, and an h-index of 17 for Xiao Dong. These figures indicate that a portion of the researcher’s indexed scholarly output has received citation attention from subsequent academic literature. The h-index represents a combined measure of publication productivity and citation distribution, while the total citation count describes citation reception across indexed documents. [4]

Award Suitability

For consideration under an Innovative Research Award in the subject area of cancer, Xiao Dong’s documented research record presents several academically relevant characteristics. These include participation in multidisciplinary cancer research, development and evaluation of tumor-responsive therapeutic platforms, integration of nanomedicine with immunotherapeutic mechanisms, and contribution to research examining biological barriers within the tumor microenvironment. [5]

Conclusion

Xiao Dong’s research profile reflects interdisciplinary work in cancer-related biomaterials, nanomedicine, tumor-responsive therapeutic systems, and cancer immunotherapy. Published research demonstrates engagement with strategies designed to combine targeted or stimulus-responsive drug activity with modulation of antitumor immunity.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Xiao Dong, Author ID 56457039700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56457039700
  2. ORCID. (n.d.). ORCID record: Xiao Dong, 0000-0001-6897-6999. ORCID.
    https://orcid.org/0000-0001-6897-6999
  3. Medical Lab Scientist Awards. (n.d.). Medical Lab Scientist Awards academic and scientific recognition platform.
    https://medicallabscientist.com/
  4. Xia, S., Wang, X., Liu, C., Ji, R., Wang, M., Zhang, C., Chen, L., Chen, W., Yao, S. Q., Fang, C., & Dong, X. (2026). Hypochlorous Acid-Responsive Prodrug Nanoplatform for Synergistic Cancer Immunotherapy. Biomaterials Research, 30, Article 0300.
    https://doi.org/10.34133/bmr.0300
  5. Wang, X., Liu, C., Ji, R., Liu, J., Shao, Y., Xia, S., Li, J., Zhang, X., Luo, L., Wu, Y., Yao, S. Q., Fang, C., Chen, L., & Dong, X. (2026). Lipid droplet-targeted biomimetic liposomes potentiate chemo-ferroptosis therapy in leukemia. Advanced Materials.
    https://doi.org/10.1002/adma.202515716

Romaric Tuono De Manfouo | Hemostasis | Innovative Research Award

Published on by Medical Lab Scientist

Innovative Research Award

Romaric Tuono De Manfouo
Affiliation Université des Montagnes
Country Cameroon
Scopus ID 57739398300
Documents 13
Citations 21
h-index 3
Subject Area Hemostasis
Event Medical Lab Scientist Awards
ORCID 0000-0002-2867-0538

Romaric Tuono De Manfouo is a Cameroon-based biomedical researcher affiliated with Université des Montagnes whose published work spans hematology, hemostasis, sickle cell disease, thrombosis-related biomarkers, anemia, iron metabolism, inflammation, and related clinical laboratory investigations. [1]

Abstract

This academic recognition profile summarizes the scholarly record of Romaric Tuono De Manfouo within hemostasis, hematology, and related biomedical sciences. His published work has examined hematological and hemostatic abnormalities in sickle cell disease, biomarkers associated with thrombotic risk, iron metabolism, inflammation, haptoglobin biology, anemia, and blood-donor health. [1]

Keywords

Hemostasis, hematology, thrombosis, thrombotic risk, plasminogen, sickle cell disease, coagulation, anemia, iron deficiency, inflammation, haptoglobin, hematological profile, laboratory medicine, blood disorders, clinical biomarkers, Cameroon, medical laboratory science. [2]

Introduction

Hemostasis is the coordinated physiological process through which vascular integrity is maintained while excessive bleeding and inappropriate thrombosis are prevented. Research in this field frequently integrates platelet biology, coagulation pathways, fibrinolysis, hematological parameters, inflammatory mechanisms, and clinical risk assessment.[2]

Research Profile

Romaric Tuono De Manfouo is affiliated with Université des Montagnes in Bangangté, Cameroon. Published articles have also identified research affiliations with the Faculty of Medicine and Biomedical Sciences of Université de Yaoundé I. His ORCID identifier, 0000-0002-2867-0538, provides a persistent scholarly identifier associated with his research output. [3]

Research Contributions

A major contribution of De Manfouo’s work is the study of thrombosis-related and hemostatic abnormalities in sickle cell disease. In a study examining hematological and hemostatic profiles in Cameroonian patients with sickle cell disease, the research focused on laboratory characteristics associated with thrombotic risk.[3]

Publications

Romaric Tuono De Manfouo’s research portfolio reflects a sustained focus on hemostasis, hematology, thrombosis, inflammation, and related clinical laboratory investigations. His publications include studies examining plasminogen as a potential marker of thrombotic risk in patients with hepatitis, hematological and hemostatic profiles associated with thrombosis in sickle cell disease, and iron status and inflammation in sickle cell populations.[4]

Research Impact

The supplied Scopus metrics indicate 13 indexed documents, 21 citations, and an h-index of 3. These indicators provide a quantitative view of publication activity and citation reception within the Scopus database, although they should not be interpreted independently of publication quality, study design, authorship contribution, disciplinary citation practices, and the clinical relevance of the underlying research. [4]

Award Suitability

For consideration under an Innovative Research Award in the subject area of hemostasis, De Manfouo’s documented research record demonstrates several academically relevant characteristics. These include investigation of thrombotic risk in sickle cell disease, evaluation of fibrinolytic biomarkers such as plasminogen, integration of hematological and inflammatory measurements.[5]

Conclusion

Romaric Tuono De Manfouo’s research profile is characterized by work at the intersection of hematology, hemostasis, inflammation, and clinical laboratory science. His studies on thrombotic risk in sickle cell disease, plasminogen during hepatitis, iron status, oxidative stress, haptoglobin, anemia, and blood-donor health demonstrate a sustained interest in laboratory-based assessment of hematological disorders and clinically relevant biomarkers. [5]

References

  1. Elsevier. (n.d.). Scopus author details: Romaric Tuono De Manfouo, Author ID 57739398300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57739398300
  2. ORCID. (n.d.). ORCID record: Romaric Tuono De Manfouo, 0000-0002-2867-0538. ORCID.
    https://orcid.org/0000-0002-2867-0538
  3. Medical Lab Scientist Awards. (n.d.). Medical Lab Scientist Awards academic and scientific recognition platform.
    https://medicallabscientist.com/
  4. Tuono, R. D. M., Tchoumke, M. M., Tepe, W. A. D., Jeuta, W. K., Fewou, S. N., et al. (2025). Plasminogen as a Marker for Assessing Thrombotic Risk During Hepatitis in Cameroon: Case-Control Study. Health Science Reports.
    https://doi.org/10.1002/hsr2.70648
  5. Simo, J. L., Angandji, P. T., Tuono, R. D. M., Njinjou, K. F., Yong, I. W. S., Njopwouo, M. S., & Chuisseu, P. D. D. (2026). Hepatic enzyme abnormalities and their association with hematological parameters in sickle cell disease A case-control study in Cameroon. Health Science Reports.
    https://doi.org/10.1002/hsr2.72649

 

Lingkai Zhang | Oncology | Innovative Research Award

Published on by Medical Lab Scientist

Innovative Research Award

Lingkai Zhang
Affiliation Fudan University
Country China
Scopus ID 59507405200
Documents 8
Citations 9
h-index 2
Subject Area Oncology
Event Medical Lab Scientist Awards
ORCID 0009-0001-0405-057X

Lingkai Zhang is a researcher affiliated with Fudan University in Shanghai, China, whose scholarly activity is associated with oncology and particularly with research into urothelial carcinoma, tumor biology, immune-cell infiltration, molecular biomarkers, and the tumor immune microenvironment. [1]

Abstract

This academic recognition profile summarizes the research record of Lingkai Zhang of Fudan University within the subject area of oncology. His published work includes investigations of urothelial carcinoma with emphasis on the tumor immune microenvironment, immune-cell infiltration, clinically relevant molecular alterations, proliferative tumor characteristics, and factors associated with patient prognosis or therapeutic response. [1]

Keywords

Oncology, urothelial carcinoma, tumor immunology, tumor immune microenvironment, natural killer cells, CD8+ T cells, ARID1A, molecular biomarkers, cancer prognosis, immunotherapy, tumor proliferation, precision oncology, immune infiltration, cancer biology, translational research. [2]

Introduction

Modern oncology increasingly integrates tumor genomics, immunology, pathology, and clinical outcome data to understand biological heterogeneity and identify variables that may influence disease progression or treatment response. Urothelial carcinoma represents an important setting for such investigations because tumor behavior may be shaped by molecular alterations together with interactions between malignant cells and immune populations in the surrounding microenvironment.[2]

Research Profile

Lingkai Zhang is affiliated with Fudan University in Shanghai, China. Published articles identify an affiliation with the National Health Commission Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University. His ORCID record is identified by 0009-0001-0405-057X, providing a persistent digital identifier for scholarly attribution. [3]

Research Contributions

A principal theme within Zhang’s documented research is the investigation of immune and molecular heterogeneity in urothelial carcinoma. One study examined natural killer cell infiltration and its relationship with sex-dependent clinical outcomes, addressing how immune-cell abundance may have distinct clinical associations across patient groups.[3]

Publications

Lingkai Zhang is a researcher affiliated with Fudan University, China, whose work focuses on oncology, particularly urothelial carcinoma and tumor immunology. His research examines the relationships between immune-cell infiltration, molecular alterations, tumor biology, prognosis, and therapeutic response.His publications include studies on natural killer cell infiltration, ARID1A loss and CD8+ T-cell infiltration, proliferative ecotypes, and TERT promoter alterations in urothelial carcinoma.[4]

Research Impact

The supplied Scopus information reports 8 indexed documents, 9 citations, and an h-index of 2 for Lingkai Zhang. These values describe the research record within the Scopus indexing environment at the time the metrics were supplied. Citation totals and h-index values are dynamic indicators and can change as publications accumulate citations and bibliographic databases update their records. [4]

Award Suitability

For consideration within an Innovative Research Award framework in oncology, Zhang’s research record contains several elements relevant to an innovation-focused academic assessment. These include investigation of the tumor immune microenvironment, integration of molecular alterations with immune-cell characteristics, evaluation of clinically relevant patient cohorts, and exploration of biological classifications associated with prognosis or therapeutic benefit. [5]

Conclusion

Lingkai Zhang’s academic profile at Fudan University is associated with oncology research focused substantially on urothelial carcinoma and its molecular and immunological heterogeneity. His published studies include investigations of natural killer cell infiltration, CD8+ T-cell activity, ARID1A-related tumor characteristics, TERT-associated disease features, and proliferation-based tumor ecotypes. [5]

References

  1. Elsevier. (n.d.). Scopus author details: Lingkai Zhang, Author ID 59507405200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59507405200
  2. ORCID. (n.d.). ORCID record: Lingkai Zhang, 0009-0001-0405-057X. ORCID.
    https://orcid.org/0009-0001-0405-057X
  3. Medical Lab Scientist Awards. (n.d.). Academic and scientific recognition platform.
    https://medicallabscientist.com/
  4. Liu, Z., Zhang, L., Jin, K., et al. (2025). ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma. Clinical Cancer Research, 31(20), 4311–4322.
    https://doi.org/10.1158/1078-0432.CCR-25-0816
  5. Zhang, L., Liu, Z., Ding, Y., Sun, J., Wu, Y., Su, X., Jin, K., et al. (2025). Natural killer cell infiltration elicits gender-dependent dichotomous clinical outcomes in urothelial carcinoma. Cancer, 131(24), e70196.
    https://doi.org/10.1002/cncr.70196

Seyed-Alireza Esmaeili | Microbiota | Innovative Research Award

Published on by Medical Lab Scientist

Innovative Research Award

Seyed-Alireza Esmaeili
Affiliation Immunology Department, Mashhad University of Medical Sciences, Mashhad, Iran
Country Iran
Scopus ID 57188748201
Documents 106
Citations 7,446
h-index 31
Subject Area Microbiota
Event Medical Lab Scientist Awards
ORCID 0000-0002-9371-4170

Assoc. Prof. Dr Seyed-Alireza Esmaeili is a researcher affiliated with the Immunology Department of Mashhad University of Medical Sciences in Iran. His indexed scholarly profile is associated with microbiota, probiotics, immunology, immune regulation, and autoimmune disease research. The research profile also includes an ORCID identifier that supports persistent attribution of scholarly work. [1]

Abstract

This academic recognition profile presents the research record of Seyed-Alireza Esmaeili, affiliated with Mashhad University of Medical Sciences in Iran. His research profile is associated with microbiota and immunology, with scholarly work addressing probiotics, immune regulation, autoimmune disorders, inflammatory mechanisms, and interactions between microbial systems and host immunity. [1]

Keywords

Microbiota, probiotics, immunology, immune regulation, autoimmune disease, systemic lupus erythematosus, rheumatoid arthritis, psoriatic arthritis, dendritic cells, macrophages, T cells, gut microbiome, oral microbiota, tolerogenic probiotics, inflammatory disease, translational immunology, biomedical research. [2]

Introduction

Microbiota research examines the relationships between microbial communities and their hosts and has become increasingly relevant to immunology, metabolic science, inflammatory disease, and translational medicine. Research into probiotics is one component of this broader field, particularly where microorganisms or microbial products are investigated for possible effects on immune signaling and physiological homeostasis. [2]

Research Profile

Seyed-Alireza Esmaeili is affiliated with the Immunology Department of Mashhad University of Medical Sciences, Mashhad, Iran. The supplied Scopus author information identifies the researcher through Author ID 57188748201 and reports 106 documents, 7,446 citations, and an h-index of 31. [3]

Research Contributions

A significant research theme is the study of tolerogenic probiotics as potential immunomodulatory agents. Research in this area has considered how probiotic organisms may influence immune tolerance and inflammatory pathways, particularly in autoimmune disorders. Work on systemic lupus erythematosus has examined potential relationships between probiotic interventions and immune-cell function. [3]

Publications

Seyed-Alireza Esmaeili’s research record comprises 106 documents, with a strong focus on microbiota, probiotics, immunology, and immune-mediated diseases. His selected publications investigate the immunoregulatory potential of tolerogenic probiotics in systemic lupus erythematosus, allergy, psoriatic arthritis, and rheumatoid arthritis, including their effects on dendritic cells, macrophages, T-cell subsets, and inflammatory responses. [4]

Research Impact

The supplied Scopus profile reports 7,446 citations and an h-index of 31 for Seyed-Alireza Esmaeili. These indicators provide quantitative measures of scholarly visibility within the relevant indexing system. Citation counts and h-index values are database-dependent and can change over time as new publications and citations are indexed. [4]

Award Suitability

The Innovative Research Award profile is presented in the subject area of microbiota. Esmaeili’s research record contains several characteristics relevant to an innovation-focused academic assessment, including sustained investigation of probiotic–immune interactions, research into tolerogenic mechanisms, application of microbiota concepts to autoimmune disease, and continued investigation of emerging host–microbiota relationships. [5]

Conclusion

Seyed-Alireza Esmaeili’s research profile is associated with microbiota, probiotics, immunology, and autoimmune disease research at Mashhad University of Medical Sciences. His scholarly work addresses microbial influences on immune regulation through research involving probiotics, dendritic cells, macrophages, T-cell responses, and microbiota-associated disease mechanisms. [5]

References

  1. Elsevier. (n.d.). Scopus author details: Seyed-Alireza Esmaeili, Author ID 57188748201. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57188748201
  2. ORCID. (n.d.). ORCID record: Seyed-Alireza Esmaeili. ORCID.
    https://orcid.org/0000-0002-9371-4170
  3. World Research Awards. (n.d.). Medical Lab Scientist Awards.
    https://medicallabscientist.com/
  4. Ahmadi-Khorram, M., Mahmoudi, M., Kheder, R. K., Rastin, M., Hatami, A., Fadaee, A., & Esmaeili, S.-A. (2025). Induction of lupus T cell subset by probiotics-matured tolerogenic dendritic cells. Food Science & Nutrition, 13(12), e71283.
    https://doi.org/10.1002/fsn3.71283
  5. Javanmardi, Z., Mahmoudi, M., Rafatpanah, H., Rezaieyazdi, Z., Shapouri-Moghaddam, A., Ahmadi, P., Mollazadeh, S., Tabasi, N. S., & Esmaeili, S.-A. (2024). Tolerogenic probiotics Lactobacillus delbrueckii and Lactobacillus rhamnosus promote anti-inflammatory profile of macrophages-derived monocytes of newly diagnosed patients with systemic lupus erythematosus. Cell Biochemistry and Function, 42(2),
    https://doi.org/10.1002/cbf.3981

Ana Claudia Oliveira Carreira | Angiogenesis | Excellence in Research Award

Published on by Medical Lab Scientist

Excellence in Research Award

Ana Claudia Oliveira Carreira
Affiliation Federal University of ABC
Country Brazil
Scopus ID 57064088000
Documents 80
Citations 2,166
h-index 22
Subject Area Angiogenesis
Event Medical Lab Scientist Awards
ORCID 0000-0002-9142-1155
Google Scholar ID E_4m1ZEAAAAJ&hl=pt-BR

Ana Claudia Oliveira Carreira is a researcher affiliated with the Federal University of ABC in Brazil, with a research profile associated with angiogenesis. The supplied Scopus information records 80 documents, 2,166 citations, and an h-index of 22.[1]

Abstract

Ana Claudia Oliveira Carreira is affiliated with the Federal University of ABC in Brazil and is identified in the supplied research information with the subject area of angiogenesis. Her Scopus profile records 80 documents, 2,166 citations, and an h-index of 22. These bibliometric indicators provide a structured overview of her documented research output and citation record.[1]

Keywords

Ana Claudia Oliveira Carreira is a researcher affiliated with the Federal University of ABC whose academic work is associated with angiogenesis and biomedical research. Her research profile is documented through Scopus, providing bibliometric information relevant to research impact and scholarly visibility.[2]

Introduction

Angiogenesis refers to the formation of new blood vessels from existing vasculature and represents an important area of biomedical research because vascular development and remodeling are relevant to physiological and pathological processes. Within this broad research context, the supplied profile identifies Ana Claudia Oliveira Carreira with angiogenesis as her subject area and documents a substantial body of indexed scholarly output. [2]

Research Profile

The supplied Scopus record identifies Ana Claudia Oliveira Carreira through Author ID 57064088000 and associates the profile with 80 documents, 2,166 citations, and an h-index of 22. The affiliation listed for the researcher is the Federal University of ABC, Brazil, while angiogenesis is provided as the principal subject area for this recognition profile. [3]

Research Contributions

Based on the supplied profile information, Carreira’s documented research contribution is represented by a body of 80 Scopus-indexed documents within a profile associated with angiogenesis. The citation record of 2,166 citations indicates that the indexed publications have accumulated citations within the Scopus database.[3]

Publications

The supplied information records 80 documents for Ana Claudia Oliveira Carreira in Scopus. The available source data in this profile does not provide a complete publication-by-publication bibliography, individual article titles, publication dates, journal details, or verified DOI identifiers. Accordingly, specific publications are not listed here beyond the documented aggregate publication count. [4]

Research Impact

The supplied bibliometric record reports 2,166 citations across 80 documents and an h-index of 22. These indicators provide quantitative information about the visibility and citation history of the indexed research record. They do not, by themselves, establish the societal, clinical, translational, or qualitative significance of individual studies. [4]

Award Suitability

For the purposes of the Excellence in Research Award profile presented here, the documented research record includes an affiliation with the Federal University of ABC, an identified subject area of angiogenesis, 80 Scopus documents, 2,166 citations, and an h-index of 22. These details provide documented bibliometric and affiliation information relevant to an academic recognition profile. [5]

Conclusion

Ana Claudia Oliveira Carreira’s supplied research profile documents an affiliation with the Federal University of ABC in Brazil and an academic focus associated with angiogenesis. The reported Scopus record comprises 80 documents, 2,166 citations, and an h-index of 22. Together with the ORCID and supplied Google Scholar identifiers, these records provide a structured basis for identifying and documenting the research profile. [5]

References

  1. Elsevier. (n.d.). Scopus author details: Ana Claudia Oliveira Carreira, Author ID 57064088000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57064088000
  2. ORCID. (n.d.). Ana Claudia Oliveira Carreira: ORCID record 0000-0002-9142-1155. ORCID.
    https://orcid.org/0000-0002-9142-1155
  3. Google Scholar. (n.d.). Researcher profile identifier supplied for Ana Claudia Oliveira Carreira: E_4m1ZEAAAAJ&hl=pt-BR. Google Scholar.
    https://scholar.google.com/citations?user=E_4m1ZEAAAAJ&hl=pt-BR
  4. Fernandes, L. A., Magalhães, G. R. I., & Carreira, A. C. O. (2025). Assays of angiogenic potential using quail and chicken chorioallantoic membrane (CAM). Current Protocols.
    https://doi.org/10.1002/cpz1.70223
  5. Almeida, G. H. D. R., Gibin, M. S., … Carreira, A. C. O. (2024). Development and biocompatibility assessment of decellularized porcine uterine extracellular matrix-derived grafts. Tissue Engineering Part C: Methods, 30(12).
    https://doi.org/10.1089/ten.tec.2024.0229

Miguel Relloso | Reproduction Immunology | Innovative Research Award

Published on by Medical Lab Scientist

Innovative Research Award

Miguel Relloso
Affiliation Instituto de Investigación Sanitaria Gregorio Marañón
Country Spain
Scopus ID 6602575402
Documents 34
Citations 1,417
h-index 21
Subject Area Reproduction Immunology
Event Medical Lab Scientist Awards
ORCID 0000-0002-9181-2244

Miguel Relloso is a researcher affiliated with the Instituto de Investigación Sanitaria Gregorio Marañón, Spain, and is associated with Reproduction Immunology. His supplied Scopus profile records 34 documents, 1,417 citations, and an h-index of 21. His researcher identity is additionally represented by ORCID 0000-0002-9181-2244.[1]

Abstract

Miguel Relloso is a researcher affiliated with the Instituto de Investigación Sanitaria Gregorio Marañón in Spain and associated with the research area of Reproduction Immunology. The supplied bibliometric profile records 34 documents, 1,417 citations, and an h-index of 21. His academic identity is further represented through ORCID identifier 0000-0002-9181-2244 and Scopus Author ID 6602575402.[1]

Keywords

Miguel Relloso; Reproduction Immunology; reproductive immunology; immunology; biomedical research; medical research; research impact; scholarly publications; bibliometrics; Scopus; ORCID; research recognition; Innovative Research Award.[2]

Introduction

Reproduction Immunology examines immunological mechanisms and interactions relevant to reproductive biology and reproductive health. Research in this interdisciplinary area may incorporate cellular, molecular, clinical, and translational approaches. Bibliographic databases can provide structured information for documenting scholarly publications, citation activity, and researcher-associated records within specialized scientific fields.[2]

Research Profile

Miguel Relloso is identified with the Instituto de Investigación Sanitaria Gregorio Marañón, Spain, and the subject area of Reproduction Immunology. His supplied Scopus Author ID is 6602575402, while his ORCID identifier is 0000-0002-9181-2244. These persistent identifiers support the association of scholarly records with an individual researcher and can assist with distinguishing researchers who have similar names.[3]

Research Contributions

The available profile information places Relloso’s research within Reproduction Immunology. His documented institutional affiliation and indexed scholarly record provide identifiable information for describing his research activity. Research affiliation: Instituto de Investigación Sanitaria Gregorio Marañón, Spain. Research area: Reproduction Immunology. Indexed scholarly documents: 34. Indexed citations: 1,417. Reported h-index: 21.[3]

Publications

The supplied information reports 34 Scopus-indexed documents and provides selected publication records associated with Miguel Relloso. These include research concerning antisperm antibodies, neutrophil-mediated sperm elimination, estradiol, CXCL1 signaling, cervical epithelial responses, and reproductive immunology. The individual publications listed in the references provide article-level bibliographic information and DOI identifiers.[4]

Research Impact

Citation count and h-index are bibliometric indicators used to describe aspects of an indexed scholarly record. The supplied information associates Relloso with 1,417 citations and an h-index of 21 across 34 documents. These indicators should therefore be treated as time-dependent measurements rather than comprehensive assessments of research quality.[4]

Award Suitability

The Innovative Research Award profile is presented in connection with the Medical Lab Scientist Awards. The supplied information documents an institutional affiliation, defined research subject area, persistent ORCID identifier, Scopus author profile, and stated bibliometric indicators.[5]

Conclusion

Miguel Relloso’s academic profile is associated with the Instituto de Investigación Sanitaria Gregorio Marañón in Spain and the research area of Reproduction Immunology. The supplied Scopus information records 34 documents, 1,417 citations, and an h-index of 21. His ORCID identifier further provides a persistent researcher reference. [5]

References

  1. Elsevier. (n.d.). Scopus author details: Miguel Relloso, Author ID 6602575402. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6602575402
  2. ORCID. (n.d.). Miguel Relloso: ORCID record. ORCID.
    https://orcid.org/0000-0002-9181-2244
  3. Medical Lab Scientist Awards. (n.d.). Medical Lab Scientist Awards.
     https://medicallabscientist.com/
  4. Arribas-Poza, P., Veiga-Fernández, A., Gómez-Oro, C., López-Escobar, N., Olivera-Valle, I., Asensio, F., Clemente, M. I., Pérez-Milán, F., & Relloso, M. (2026). Role of antisperm antibodies in neutrophil-mediated sperm elimination by trogocytosis. Andrology. https://doi.org/10.1111/andr.70315
  5. Salinas-Muñoz, L., Campos-Fernández, R., Olivera-Valle, I., Mercader, E., Fernandez-Pacheco, C., Lasarte, S., Pérez-Martín, L., Navarro-González, M. T., Sánchez-Mateos, P., Samaniego, R., & Relloso, M. (2019). Estradiol impairs epithelial CXCL1 gradient in the cervix to delay neutrophil transepithelial migration during insemination. Journal of Reproductive Immunology, 133, 7–14.
    https://doi.org/10.1016/j.jri.2019.02.002

Rashad Al-Salahi | Synthetic Organic Chemistry | Research Excellence Award

Published on by Medical Lab Scientist

Research Excellence Award

Rashad Al-Salahi
Affiliation King Saud University College of Pharmacy
Country Saudi Arabia
Google Scholar ID UTud5WAAAAAJ&hl=ar
Documents 187
Citations 2,674
h-index 28
Subject Area Synthetic Organic Chemistry
Event Medical Lab Scientist Awards
ORCID 0000-0003-1747-2736

Rashad Al-Salahi is a researcher affiliated with King Saud University College of Pharmacy in Saudi Arabia whose stated subject area is synthetic organic chemistry. The supplied research-profile data record 187 documents, 2,674 citations, and an h-index of 28. These bibliometric indicators provide quantitative information about the documented publication and citation record associated with the researcher profile. [1]

Abstract

Rashad Al-Salahi is a researcher affiliated with King Saud University College of Pharmacy, Saudi Arabia, with synthetic organic chemistry identified as his principal subject area. The supplied academic profile records 187 documents, 2,674 citations, and an h-index of 28. His ORCID identifier is 0000-0003-1747-2736, supporting persistent identification within scholarly communication systems.[1]

Keywords

Rashad Al-Salahi, Synthetic Organic Chemistry, Organic Chemistry, Pharmaceutical Chemistry, Medicinal Chemistry, Chemical Biology, Organic Synthesis, Drug Discovery, Molecular Research, Pharmaceutical Research, Research Excellence, Academic Research, Research Impact, Bibliometrics, Scholarly Communication, King Saud University College of Pharmacy, Saudi Arabia, Medical Lab Scientist Awards.[2]

Introduction

Synthetic organic chemistry focuses on the design, preparation, modification, and characterization of organic compounds. It has applications across pharmaceutical chemistry, medicinal chemistry, chemical biology, and related scientific disciplines. Al-Salahi’s supplied profile identifies this field as his primary subject area and associates his research activity with King Saud University College of Pharmacy in Saudi Arabia.[2]

Research Profile

Rashad Al-Salahi is affiliated with King Saud University College of Pharmacy. The supplied profile identifies synthetic organic chemistry as his subject area and reports 187 documents, 2,674 citations, and an h-index of 28. His ORCID identifier provides a persistent mechanism for distinguishing his scholarly identity across research and publishing systems.[3]

Research Contributions

The stated research area of synthetic organic chemistry encompasses the development, synthesis, modification, and characterization of organic molecules. Such research can support pharmaceutical and biomedical investigations through the preparation of chemically defined compounds and related methodologies. Specific contributions should be assessed through individual publications, experimental findings, collaborations, and documented scholarly outputs.[3]

Publications

The supplied researcher profile contains 187 documents. However, individual publication titles, journals, publication dates, and DOI identifiers were not provided in the available information. Therefore, specific publications are not listed here to avoid unsupported attribution. Individual bibliographic records should be verified through recognized scholarly databases, publisher records, persistent identifiers, or the researcher’s authenticated profiles.[4]

Research Impact

The supplied profile reports 2,674 citations and an h-index of 28 across 187 documents. These indicators provide quantitative information about publication and citation activity within the underlying research profile. Bibliometric values may vary between databases because of indexing coverage, author identification, document inclusion, and update schedules, and should therefore be interpreted within their specific database context.[4]

Award Suitability

The supplied academic information presents a researcher affiliated with King Saud University College of Pharmacy and working in synthetic organic chemistry. The documented profile includes 187 documents, 2,674 citations, and an h-index of 28. These details may form part of an academic recognition profile, subject to the published eligibility requirements and verification procedures of the relevant award program.[5]

Conclusion

Rashad Al-Salahi’s supplied profile identifies King Saud University College of Pharmacy as his affiliation and synthetic organic chemistry as his research area. The reported record includes 187 documents, 2,674 citations, and an h-index of 28. Together with his ORCID identifier, these details provide a structured overview of his documented academic profile and research activity.[5]

References

  1. ORCID. (n.d.). Rashad Al-Salahi, ORCID iD 0000-0003-1747-2736. ORCID.
    https://orcid.org/0000-0003-1747-2736
  2. Google Scholar. (n.d.). Rashad Al-Salahi, Google Scholar profile.
    https://scholar.google.com/citations?user=UTud5WAAAAAJ&hl=ar
  3. Medical Lab Scientist Awards. (n.d.). Medical Lab Scientist Awards.
    https://medicallabscientist.com/
  4. Mohamed, S. K., Siddique, S. A., Sarfraz, M., Ashfaq, M., Khamies, E., Bakhite, E. A., El-Emary, T. I., Smerat, A., Al-Salahi, R., & El Bakri, Y. (2026). Synthesis, structural characterization, DFT analysis, drug likeness evaluation, and molecular docking studies of new tetrahydroisoquinolines against viral and cancer protein targets. New Journal of Chemistry, 50(34), 14528–14546.
    https://doi.org/10.1039/d6nj01327a
  5. Abuelizz, H. A., Soltan, M. M., Marzouk, M., Awad, H. M., Abo-Salem, H. M., Abdellatif, M. M., Mostafa, G. A. E., Ali, E. A., & Al Salahi, R. (2026). Dichlorophthalic anhydride derivatives as anti-apoptotic and antiproliferative agents by multi-targeted mechanism: Biological evaluation and molecular docking studies. Journal of Biochemical and Toxicology.
    https://doi.org/10.1002/jbt.70727

Tingting Liu | Atherosclerosis | Innovative Research Award

Published on by Medical Lab Scientist

Innovative Research Award

Tingting Liu
Affiliation Hunan University of Chinese Medicine
Country China
Documents 6
Subject Area Atherosclerosis
Event Medical Lab Scientist Awards
ORCID 0009-0004-1547-5866

Tingting Liu is a researcher affiliated with Hunan University of Chinese Medicine in China whose stated research subject area is atherosclerosis. The research profile is associated with the ORCID identifier 0009-0004-1547-5866. This academic recognition page presents the researcher’s institutional affiliation, subject area, research profile information, and relevant scholarly resources in a structured format.[1]

Abstract

Tingting Liu is affiliated with Hunan University of Chinese Medicine, China, and is identified with the research subject area of atherosclerosis. The profile is linked to an ORCID record that provides a persistent identifier for the researcher and supports the association of scholarly activities with the appropriate researcher identity.This page provides a structured academic overview of the available researcher information in relation to the Innovative Research Award and the Medical Lab Scientist Awards.[1]

Keywords

Tingting Liu, Hunan University of Chinese Medicine, China, atherosclerosis, cardiovascular research, vascular biology, biomedical research, medical laboratory science, research recognition, Innovative Research Award, Medical Lab Scientist Awards, ORCID clinical research, cardiovascular disease research,and translational medicine..[2]

Introduction

Atherosclerosis is a chronic vascular condition involving pathological changes in arterial walls and is an important area of investigation within cardiovascular and biomedical research. Research in this field may involve molecular mechanisms, cellular responses, biomarkers, vascular biology, experimental models, and diagnostic approaches.[2]

Research Profile

Tingting Liu is a researcher at Hunan University of Chinese Medicine, China, whose research focuses on atherosclerosis. The available profile identifies Tingting Liu as a researcher at Hunan University of Chinese Medicine, China, with a research subject area in atherosclerosis. The ORCID record provides a persistent digital identifier that can be used to distinguish the researcher from other scholars with similar names and to connect relevant research outputs where those records have been registered.[3]

Research Contributions

The stated research subject of atherosclerosis places the profile within a multidisciplinary area connecting vascular biology, cardiovascular science, molecular research, laboratory investigation, and clinical research. Research contributions in this domain may address mechanisms underlying vascular disease, biological markers, cellular and molecular pathways, experimental investigation, and approaches to understanding disease progression.[3]

Publications

No specific publication titles, journal records, DOI identifiers, or bibliographic details for Tingting Liu were supplied with the profile information used for this page. Consequently, individual publications are not listed here to avoid attributing articles to a researcher without sufficient bibliographic verification.[4]

Research Impact

Research impact can be documented through several forms of evidence, including peer-reviewed publications, citations, scholarly collaborations, research outputs, and contributions to the scientific literature. Citation-based indicators such as citation counts and h-index values should be interpreted in relation to the database used, disciplinary norms, publication period, and date of measurement..[4]

Award Suitability

The Innovative Research Award profile is associated with Tingting Liu based on the supplied institutional affiliation and research subject area. The identified subject area, atherosclerosis, represents an established field of biomedical and cardiovascular research and can be relevant to research-oriented recognition programs concerned with scientific investigation and laboratory-related disciplines..[5]

Conclusion

Tingting Liu is affiliated with Hunan University of Chinese Medicine in China and is identified with a research focus in atherosclerosis. The researcher is associated with ORCID identifier 0009-0004-1547-5866, which provides a persistent mechanism for researcher identification and scholarly record linkage.The available information supports a concise academic recognition profile while leaving publication and bibliometric details open for verification through authoritative scholarly databases..[5]

References

    1. ORCID. (n.d.). ORCID record: Tingting Liu, ORCID iD 0009-0004-1547-5866. ORCID.
      https://orcid.org/0009-0004-1547-5866
    2. Medical Lab Scientist Awards. (n.d.). Medical Lab Scientist Awards.
      https://medicallabscientist.com/
    3. Liu, T., Luo, Q., Yang, S., Yang, D., Lv, X., Zhao, L., & Tuo, Q. (2026). INO80E suppresses oxidized LDL-induced endothelial apoptosis through HDAC1-mediated stabilization of YY1. Biomolecules, 16(8), 1174.
      https://doi.org/10.3390/biom16081174
    4. Sun, T., Luo, Q., Liu, T., Lv, X., Lin, L., Liao, D., Tuo, Q., & Chen, W. (2026). Rosmarinic acid targets AKR1B1 to ameliorate atherosclerosis via vascular endothelial cell energy metabolism regulation. Biomolecules, 16(3), 403.
      https://doi.org/10.3390/biom16030403
    5. Liu, T.-T., Wang, Q., Zhou, Y., Ye, B., Liu, T., Yan, L., Fan, J., Xu, J., Zhou, Y., Xia, Z., & Deng, X. (2024). Discovery of a meisoindigo-derived PROTAC as the ATM degrader: Revolutionizing colorectal cancer therapy via synthetic lethality with ATR inhibitors. Journal of Medicinal Chemistry, 67(9), 7620–7634.
      https://doi.org/10.1021/acs.jmedchem.4c00454

Uttara Chakraborty | Mesenchymal Stem Cells | Women Researcher Award

Published on by Medical Lab Scientist

Women Researcher Award

Uttara Chakraborty
Affiliation Manipal Institute of Regenerative Medicine
Country India
Scopus ID 57220076644
Documents 11
Citations 62
h-index 4
Subject Area Mesenchymal Stem Cells
Event Medical Lab Scientist Awards
Google Scholar ID jGLPqU4AAAAJ

Uttara Chakraborty is a researcher affiliated with the Manipal Institute of Regenerative Medicine, India, whose indexed research record includes work related to mesenchymal stem cells. Her Scopus author profile records 11 documents, 62 citations, and an h-index of 4 at the time of reference to the indexed record. The profile is presented in the context of academic recognition associated with the Medical Lab Scientist Awards. The information below summarizes the supplied bibliometric record and research area without making claims beyond the available indexed-profile information.[1]

Abstract

Uttara Chakraborty is affiliated with the Manipal Institute of Regenerative Medicine and is associated with research in the area of mesenchymal stem cells. The supplied Scopus record identifies 11 indexed documents, 62 citations, and an h-index of 4. Her academic profile can also be accessed through Google Scholar, providing an additional source for reviewing her scholarly publications and citation record.[1]

Keywords

The research profile encompasses mesenchymal stem cells, stem cell research, regenerative medicine, cell biology, biomedical research, research impact, and scholarly publications, reflecting an academic focus on cellular science and its potential applications in regenerative and biomedical research. .[2]

Introduction

Mesenchymal stem cells are multipotent stromal cells that have been investigated extensively in regenerative medicine, tissue engineering, immunomodulation, and related biomedical fields. Research involving these cells encompasses their biological characteristics, differentiation potential, interactions with surrounding tissues, and possible applications in disease research and therapeutic development.[2]

Research Profile

The supplied bibliometric profile associates Uttara Chakraborty with the Manipal Institute of Regenerative Medicine in India and identifies mesenchymal stem cells as the principal subject area for this recognition profile. The Scopus author identifier is 57220076644. The indexed record supplied for this article contains 11 documents, 62 citations, and an h-index of 4.[3]

Research Contributions

The identified research area of mesenchymal stem cells places the profile within the wider field of regenerative medicine and biomedical research. Research in this area may address cellular properties, stem-cell biology, differentiation, tissue repair, translational applications, and interactions between cells and their biological environment.[3]

Publications

The supplied Scopus profile identifies 11 indexed documents associated with the researcher identifier 57220076644. The Google Scholar profile provides an additional bibliographic source for reviewing publications and citation information. Because individual publication titles, journal details, publication years, and DOI identifiers were not supplied as part of the source data for this article, no specific publication or DOI has been attributed to the researcher without verification.[4]

Research Impact

The supplied Scopus record reports 62 citations across 11 documents and an h-index of 4. These indicators describe citation activity recorded by the database and can be used as bibliometric reference points when reviewing the profile. Citation-based measures should be interpreted alongside the research field, publication history, database coverage, authorship patterns, and time since publication. .[4]

Award Suitability

The profile has been prepared in relation to the Medical Lab Scientist Awards. The documented research area, affiliation, indexed publications, citations, and h-index provide factual information that may be considered as part of an academic recognition profile. Award eligibility or selection should be determined according to the applicable award criteria and review process.[5]

Conclusion

Uttara Chakraborty’s academic profile is associated with the Manipal Institute of Regenerative Medicine and research in mesenchymal stem cells. The supplied Scopus record documents 11 indexed documents, 62 citations, and an h-index of 4. Together with the linked Google Scholar profile, these records provide reference points for reviewing her scholarly activity and research impact.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Uttara Chakraborty, Author ID 57220076644. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57220076644
  2. Google Scholar. (n.d.). Uttara Chakraborty — Google Scholar profile.
    https://scholar.google.com/citations?hl=en&user=jGLPqU4AAAAJ
  3. Medical Lab Scientist Awards. (n.d.). Medical Lab Scientist Awards.
    https://medicallabscientist.com/
  4. Saroj, P. B., Gupta, A., James, A. B., Nala, N., & Chakraborty, U. (2025). Establishing a workflow towards understanding osteogenic lineage commitment of enriched homogeneous populations of human dental pulp stem cells. Current Protocols, 5, Article e70297.
    https://doi.org/10.1002/cpz1.70297
  5. Mukhopadhyay, R., Varshitha, D. V., Telford, W. G., Sanders, C. K., & Chakraborty, U. (2023). Mammalian chromosome analysis and sorting by flow cytometry. Current Protocols, 3(6), e785.
    https://doi.org/10.1002/cpz1.785

João Felício | Endocrinology | Innovative Research Award

Published on by Medical Lab Scientist

Innovative Research Award

João Felício
Affiliation Federal University of Pará
Country Brazil
Scopus ID 6701708794
Documents 70
Citations 10,824
h-index 24
Subject Area Endocrinology
Event Medical Lab Scientist Awards
ORCID 0000-0003-4002-988X

João Felício is a researcher affiliated with the Federal University of Pará in Brazil whose indexed scholarly record is associated with the field of endocrinology. The available Scopus profile information lists 70 documents, 10,824 citations, and an h-index of 24.His ORCID identifier provides a persistent researcher identifier for distinguishing his scholarly contributions from those of other researchers. [1]

Abstract

This academic recognition profile presents the research record of João Felício, affiliated with the Federal University of Pará, Brazil. The profile identifies endocrinology as the principal subject area and summarizes selected bibliometric indicators reported for the researcher’s Scopus author record, including 70 documents, 10,824 citations, and an h-index of 24. These indicators provide a quantitative description of indexed scholarly output and citation activity, while the ORCID record provides an additional persistent identifier for scholarly attribution. [1]

Keywords

Endocrinology, medical research, biomedical science, research impact, bibliometrics, scholarly communication, and research recognition are interconnected areas that support the advancement, evaluation, and dissemination of scientific knowledge. Endocrinology focuses on the study of hormones, glands, and related physiological processes, while medical research and biomedical science contribute to understanding diseases, developing diagnostic approaches, and improving healthcare. Bibliometrics provides quantitative methods for examining scholarly publications and citation patterns, whereas scholarly communication facilitates the sharing of research findings among academic and scientific communities. [2]

Introduction

Academic recognition profiles commonly use bibliographic databases and persistent researcher identifiers to describe scholarly activity. Scopus provides author-level bibliometric information associated with indexed publications, while ORCID provides a persistent identifier intended to support accurate attribution of research contributions. [2]

Research Profile

João Felício’s research profile is associated with the Federal University of Pará in Brazil and the subject area of endocrinology. The supplied Scopus record identifies the author with Scopus Author ID 6701708794 and reports 70 indexed documents, 10,824 citations, and an h-index of 24.The available profile information documents a body of indexed scholarly work within a research context associated with endocrinology. The reported total of 70 documents provides an indication of the volume of publications represented in the supplied Scopus record.Interpretation of individual contributions requires examination of the underlying publications, their research questions, methodologies, collaborative networks, and venues of publication. [3]

Publications

The supplied Scopus information reports 70 documents associated with the author identifier 6701708794.The available source information does not provide a complete publication-by-publication bibliography for inclusion in this article. Consequently, individual publication titles, journals, publication years, and DOI identifiers should be verified against the underlying bibliographic records before being added to a formal publication list.[3]

Research Impact

The supplied Scopus record reports 10,824 citations and an h-index of 24 for João Felício. Citation count measures the number of citations represented in the relevant database, while the h-index is a bibliometric indicator combining publication and citation information. Such measures can vary between databases and over time because of differences in indexing coverage, author disambiguation, document types, and citation updates.[4]

Award Suitability

The profile is presented in connection with the recognition category identified as the Innovative Research Award. The supplied academic information provides documented research indicators that can be considered as part of an academic recognition profile. Eligibility or final award decisions, however, depend on the applicable award criteria and review procedures rather than on bibliometric indicators alone.[4]

Conclusion

João Felício is affiliated with the Federal University of Pará in Brazil and has a research profile associated with endocrinology. The supplied Scopus record reports 70 documents, 10,824 citations, and an h-index of 24, while the ORCID record provides a persistent identifier for the researcher. These data provide a structured bibliometric overview suitable for an academic recognition profile, while detailed evaluation of research significance requires consideration of the underlying scholarly outputs and applicable award criteria.[5]

References

  1. Elsevier. (n.d.). Scopus author details: João Felício, Author ID 6701708794. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6701708794
  2. ORCID. (n.d.). ORCID record: João Felício. ORCID.
    https://orcid.org/0000-0003-4002-988X
  3. World Research Awards. (n.d.). Medical Lab Scientist Awards.
    https://medicallabscientist.com/
  4. Felício, J. S., de Souza, A. C. C. B., Kohlmann, N., Kohlmann, O., Ribeiro, A. B., & Zanella, M. T. (2010). Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes. Cardiovascular Diabetology, 9, 36.
    https://doi.org/10.1186/1475-2840-9-36
  5. Felício, J. S., Ruivo, L. O., Bezerra, I. S., do Carmo, M. E. N. A., Fernandes, I. J., Lobo, B. D., Silva, L. de S. D. A., de Melo, F. T. C., de Souza, A. C. C. B., de Queiroz, N. N. M., dos Santos, M.C.,de Moraes, L.V.,Barros,. Vitamin D in type 2 diabetes mellitus according to diabetic kidney disease stage: What is the target in clinical practice? Nutrients, 18(9), 1408.
    https://doi.org/10.3390/nu18091408